Effects of Different Telerehabilitation Methods In Patients With Hypertension (TELE-HT)

NCT07363447 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2026-01-23

No results posted yet for this study

Summary

This study aims to compare two different ways of providing exercise therapy to people with high blood pressure (hypertension) through digital technology. Participants are divided into two groups: one group performs exercises at home while being watched and guided by a physiotherapist in real-time through video calls (synchronous). The other group performs the same exercises by watching pre-recorded videos on their own (asynchronous). The study measures how these two methods affect the patients' exercise capacity, daily blood pressure levels, heart functions, and their ability to manage their own health over an 8-week period.

Conditions

Interventions

BEHAVIORAL

Synchronous Cardiac Telerehabilitation

An 8-week aerobic-based calisthenics program consisting of 24 sessions (3 sessions/week, 45 minutes each). Exercises are performed in real-time under the live supervision of a physiotherapist via videoconferencing (WhatsApp). Intensity is maintained at 70-85% of age-predicted maximum heart rate, monitored in real-time using a wearable smartband. Exercises include high knees, knee-to-elbow, side jacks, and other calisthenics.

BEHAVIORAL

Asynchronous Cardiac Telerehabilitation

The same 8-week aerobic-based calisthenics program (24 sessions, 3 sessions/week) as the STR group. Exercises are performed independently by participants using pre-recorded video content. Participants maintain an exercise diary to record heart rate and blood pressure levels, which are reviewed weekly by a physiotherapist. Exercise intensity is adjusted weekly based on data from the participant's wearable smartband.

Sponsors & Collaborators

  • Bozok University

    collaborator OTHER
  • Hacettepe University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-28
Primary Completion
2024-07-30
Completion
2024-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07363447 on ClinicalTrials.gov